Numerous studies have shown that KIF18B may act as an oncogene in solid tumors, such as colon adenocarcinoma, cervical cancer, osteosarcoma, lung adenocarcinoma, pancreatic ductal adenocarcinoma and HCC [20–25]. Here, KIF18B is linked to hepatocellular carcinoma.